Insitro Stock

Insitro is revolutionizing pharmaceutical R&D by leveraging machine learning for drug discovery.

Sign up today and learn more about Insitro Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Insitro Stock

Over the past decades, developing drugs has become increasingly more difficult and expensive, leaving many patients with significant unmet need. A constellation of technologies now allows us to construct, perturb, and observe biological model systems in the laboratory, allowing the generation of biomolecular data at unprecedented breadth and scale. At the same time, the tools of data science and machine learning are now solving problems previously thought to be decades away from solution. We aim to combine these technologies to develop a new approach to drug development that might help us cure more people, sooner, and at a much lower cost.

Investors

Funding History

May 2018$0

Management

Founder & CEO

Daphne Koller

Press

thepharmaletter - Nov, 3 2020

News - Bristol-Myers Squibb, Digital Pharma

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo